卵圆孔未闭导致反复缺血性卒中一例

doi:10.3760/cma.j.cn101202-20200527-00175

摘要
图/表
参考文献(9)
相关文章 (4)

[1]	Amarenco P, Bogousslavsky J, Caplan LR, et al. Classification of stroke subtypes[J]. Cerebrovasc Dis, 2009, 27(5): 493-501. DOI:10.1159 /000210432.
[2]	Jickling GC, Stamova B, Ander BP, et al. Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location[J]. Stroke, 2012, 43(8): 2036-2041. DOI:10.1161/STROKEAHA.111.648725.
[3]	Larrue V, Massabuau P. Patent foramen ovale and ischemic stroke[J]. Minerva Med, 2012, 103(3): 199-207.
[4]	Del Sette M, Rizzi D, Pretta S, et al. Magnitude of right-to-left shunt as the only determinant of stroke in a pair of identical twins[J]. Neurol Sci, 2004, 25(3): 148-150. DOI:10.1007/s10072-004-0250-3.
[5]	Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography[J]. Stroke, 1993, 24(12): 1865-1873. DOI:10.1161/ 01.str.24.12.1865.
[6]	Bronzetti G, D'Angelo C, Donti A, et al. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke[J]. Int J Cardiol, 2011, 146(1): 17-21. DOI:10.1016/j.ijcard.2009.05.035.
[7]	中华医学会心血管内科分会, 中国医师协会心血管内科分会. 卵圆孔未闭预防性封堵术中国专家共识[J]. 中国循环杂志, 2017, 32(3): 209-214. DOI:10.3969/j.issn.1000-3614.2017.03.001.
[8]	De Rosa S, Sievert H, Sabatino J, et al. Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale: a systematic review and meta-analysis[J]. Ann Intern Med, 2018, 168(5): 343-350. DOI:10.7326/M17-3033.
[9]	Shah R, Nayyar M, Jovin IS, et al. Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis[J]. Ann Intern Med, 2018, 168(5): 335-342. DOI:10.7326/M17-2679.